- Home
- BWMX vs CRVS Comparison
BWMX vs CRVS Comparison
Compare BWMX & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWMX
- CRVS
- Stock Information
- Founded
- BWMX 1995
- CRVS 2014
- Country
- BWMX Mexico
- CRVS United States
- Employees
- BWMX N/A
- CRVS N/A
- Industry
- BWMX Catalog/Specialty Distribution
- CRVS Biotechnology: Pharmaceutical Preparations
- Sector
- BWMX Consumer Discretionary
- CRVS Health Care
- Exchange
- BWMX Nasdaq
- CRVS Nasdaq
- Market Cap
- BWMX 354.5M
- CRVS 328.5M
- IPO Year
- BWMX N/A
- CRVS 2016
- Fundamental
- Price
- BWMX $8.86
- CRVS $4.08
- Analyst Decision
- BWMX Strong Buy
- CRVS Strong Buy
- Analyst Count
- BWMX 1
- CRVS 4
- Target Price
- BWMX $22.50
- CRVS $15.00
- AVG Volume (30 Days)
- BWMX 55.8K
- CRVS 822.1K
- Earning Date
- BWMX 07-24-2025
- CRVS 08-05-2025
- Dividend Yield
- BWMX 16.07%
- CRVS N/A
- EPS Growth
- BWMX N/A
- CRVS N/A
- EPS
- BWMX 0.74
- CRVS N/A
- Revenue
- BWMX $684,841,453.00
- CRVS N/A
- Revenue This Year
- BWMX $4.90
- CRVS N/A
- Revenue Next Year
- BWMX $6.07
- CRVS N/A
- P/E Ratio
- BWMX $11.48
- CRVS N/A
- Revenue Growth
- BWMX 4.87
- CRVS N/A
- 52 Week Low
- BWMX $7.00
- CRVS $1.75
- 52 Week High
- BWMX $16.04
- CRVS $10.00
- Technical
- Relative Strength Index (RSI)
- BWMX 55.02
- CRVS 54.66
- Support Level
- BWMX $8.04
- CRVS $3.55
- Resistance Level
- BWMX $9.15
- CRVS $4.33
- Average True Range (ATR)
- BWMX 0.37
- CRVS 0.29
- MACD
- BWMX 0.16
- CRVS -0.01
- Stochastic Oscillator
- BWMX 80.67
- CRVS 57.94
About BWMX Betterware de Mexico S.A.P.I. de C.V.
Betterware de Mexico SAPI de CV is a direct-to-consumer selling company. The company operates through two business segments: the home organization products (Betterware segment or BWM segment) and the beauty and personal care products (B and PC) (JAFRA segment). The Betterware's segment is divided in seven categories of the home organization: Kitchen and food preservation, Home solutions, Bedroom, Bathroom, Laundry & Cleaning, Tech & mobility and wellness. The JAFRA's segment is divided into four categories beauty and personal care: fragrance, color (cosmetics), skin care and toiletries. The company generates a majority of its revenue from the Beauty and personal care (B&PC) (JAFRA segment). Geographically, key revenue for the company is derived from Mexico.
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).